European Pharmaceutical Review

MARCH 9, 2023

The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). It’s a collaborative approach from safety, engineering, toxicology, and operations to have the most robust potent compound safety. What are the safe handling procedures for companies working with HPAPIs?

Safety 98

Safety Pharmacology Training Manufacturing 98

Pharmaceutical Technology

JULY 26, 2022

NewAmsterdam Pharma has signed a definitive business combination agreement with special purpose acquisition company (SPAC) Frazier Lifesciences Acquisition (FLAC). This pro forma cash balance of nearly $470m is anticipated to offer a cash runway for the merged company through 2026.

Pharma 59

Pharma Specialization Healthcare Healthcare 59

European Pharmaceutical Review

FEBRUARY 7, 2023

In addition, the devices must not present an unacceptable risk to patient and user health and safety as established in Articles 94 and 95 of the MDR. Edward helps clients with compliance and safety issues, including in the development, launch and marketing of new products. of the MDR and Article 110.4

Medical 117

Medical Government Marketing Medicine 117